Top Pharmaceuticals companies in Norway by Net Cash Used Provided By Financing Activities

This ranking features the top 7 Pharmaceuticals companies in Norway ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD 27.80 M, for February 07, 2025.
#
Name
Net Cash Used Provided By Financing Activities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 22.08 M
Dec. 31, 2023 USD 0.73 3.02%

Norway

2
USD 8.17 M
Dec. 31, 2023 USD 2.21 -0.65%

Norway

3
USD 3.72 M
Dec. 31, 2023 USD 1.13 -2.55%

Norway

4
USD -32.59
Dec. 31, 2023 USD 0.23 0.55%

Norway

5
USD -194.52 K
Dec. 31, 2024 USD 0.19 -0.80%

Norway

6
USD -451.41 K
Dec. 31, 2023 USD 4.31 4.92%

Norway

7
USD -5.53 M
Dec. 31, 2023 USD 5.25 2.05%

Norway

Frequently Asked Questions
  • Which Pharmaceuticals company in Norway has the highest Net Cash Used Provided By Financing Activities ?

    The Pharmaceuticals company in Norway with the highest Net Cash Used Provided By Financing Activities is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD 22.08 M.

  • Which Pharmaceuticals company in Norway has the lowest Net Cash Used Provided By Financing Activities ?

    The Pharmaceuticals company in Norway with the lowest Net Cash Used Provided By Financing Activities is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD -5.53 M.

SV Wall Street